ArticleFrontiers in artificial intelligence2023
Model-agnostic explainable artificial intelligence tools for severity prediction and symptom analysis on Indian COVID-19 data.
Article in Frontiers in artificial intelligence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A comprehensive review of explainable artificial intelligence in healthcare methods, evaluation, and clinical integration.iScience · 2026Review
- Leveraging machine learning algorithm to predict minimum dietary diversity among children aged 6-23 months in Ethiopia.PLOS global public health · 2026Article
- Machine learning analysis of survival outcomes in breast cancer patients treated with chemotherapy, hormone therapy, surgery, and radiotherapy.Scientific reports · 2025Article
- Odor classification: Exploring feature performance and imbalanced data learning techniques.PloS one · 2025Article
- Article
- Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles.International journal of molecular sciences · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The COVID-19 pandemic had a global impact and created an unprecedented emergency in healthcare and other related frontline sectors. Various Artificial-Intelligence-based models were developed to effectively manage medical resources and identify patients at high risk. However, many of these AI models were limited in their practical high-risk applicability due to their "black-box" nature, i.e., lack of interpretability of the model. To tackle this problem, Explainable Artificial Intelligence (XAI) was introduced, aiming to explore the "black box" behavior of machine learning models and offer definitive and interpretable evidence. XAI provides interpretable analysis in a human-compliant way, thus boosting our confidence in the successful implementation of AI systems in the wild. Methods: In this regard, this study explores the use of model-agnostic XAI models, such as SHapley Additive exPlanations values (SHAP) and Local Interpretable Model-Agnostic Explanations (LIME), for COVID-19 symptom analysis in Indian patients toward a COVID severity prediction task. Various machine learning models such as Decision Tree Classifier, XGBoost Classifier, and Neural Network Classifier are leveraged to develop Machine Learning models. Results and discussion: The proposed XAI tools are found to augment the high performance of AI systems with human interpretable evidence and reasoning, as shown through the interpretation of various explainability plots. Our comparative analysis illustrates the significance of XAI tools and their impact within a healthcare context. The study suggests that SHAP and LIME analysis are promising methods for incorporating explainability in model development and can lead to better and more trustworthy ML models in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.